Eric G. Meissner

2.6k total citations
69 papers, 1.3k citations indexed

About

Eric G. Meissner is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Eric G. Meissner has authored 69 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 31 papers in Hepatology and 25 papers in Infectious Diseases. Recurrent topics in Eric G. Meissner's work include Hepatitis C virus research (29 papers), HIV Research and Treatment (18 papers) and Liver Disease Diagnosis and Treatment (15 papers). Eric G. Meissner is often cited by papers focused on Hepatitis C virus research (29 papers), HIV Research and Treatment (18 papers) and Liver Disease Diagnosis and Treatment (15 papers). Eric G. Meissner collaborates with scholars based in United States, Germany and Nigeria. Eric G. Meissner's co-authors include Henry Masur, Shyam Kottilil, Anu Osinusi, John G. McHutchison, Ludmila Prokunina‐Olsson, Dan E. Sturdevant, Shyamasundaran Kottilil, Lishan Su, Lishan Su and Dimitra Bon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Eric G. Meissner

66 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric G. Meissner United States 21 666 629 283 266 225 69 1.3k
Thomas Kuntzen United States 18 681 1.0× 479 0.8× 431 1.5× 385 1.4× 182 0.8× 37 1.2k
Norma Rallón Spain 22 638 1.0× 620 1.0× 429 1.5× 550 2.1× 402 1.8× 99 1.4k
H.‐H. Brackmann Germany 24 501 0.8× 418 0.7× 124 0.4× 186 0.7× 239 1.1× 65 2.1k
Daniel S. Fierer United States 18 506 0.8× 555 0.9× 122 0.4× 176 0.7× 269 1.2× 36 1.0k
Rosemary Ffrench Australia 20 687 1.0× 748 1.2× 488 1.7× 300 1.1× 198 0.9× 43 1.5k
Barbara McGovern United States 5 1.0k 1.5× 831 1.3× 273 1.0× 186 0.7× 385 1.7× 7 1.4k
Deborah Casson United States 9 638 1.0× 454 0.7× 467 1.7× 150 0.6× 83 0.4× 10 1.0k
W. P. Schaasberg Netherlands 17 925 1.4× 891 1.4× 184 0.7× 150 0.6× 169 0.8× 23 1.6k
Tilman Gerlach Germany 19 1.9k 2.8× 1.6k 2.5× 689 2.4× 161 0.6× 185 0.8× 25 2.4k
Fayez M. Hamzeh United States 22 633 1.0× 986 1.6× 77 0.3× 184 0.7× 388 1.7× 42 1.7k

Countries citing papers authored by Eric G. Meissner

Since Specialization
Citations

This map shows the geographic impact of Eric G. Meissner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric G. Meissner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric G. Meissner more than expected).

Fields of papers citing papers by Eric G. Meissner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric G. Meissner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric G. Meissner. The network helps show where Eric G. Meissner may publish in the future.

Co-authorship network of co-authors of Eric G. Meissner

This figure shows the co-authorship network connecting the top 25 collaborators of Eric G. Meissner. A scholar is included among the top collaborators of Eric G. Meissner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric G. Meissner. Eric G. Meissner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Meissner, Eric G., et al.. (2024). Candida auris cluster in a center with no previous infections associated with a single organ donor. SHILAP Revista de lepidopterología. 4(S1). s128–s128.
3.
Sonawane, Kalyani, Eric G. Meissner, Haluk Damgacioglu, et al.. (2024). Human Papillomavirus Vaccination Among Young Adults Before and During the COVID-19 Pandemic. JAMA Network Open. 7(2). e2356875–e2356875. 12 indexed citations
4.
Muiruri, Charles, Carrie Dombeck, April C. Pettit, et al.. (2024). Specialty Care Referral for Underrepresented Minorities Living with HIV in the United States: Experiences, Barriers, and Facilitators. AIDS Patient Care and STDs. 38(6). 259–266. 4 indexed citations
5.
Bloomfield, Gerald S., C. Larry Hill, Karen Chiswell, et al.. (2023). Cardiology Encounters for Underrepresented Racial and Ethnic Groups with Human Immunodeficiency Virus and Borderline Cardiovascular Disease Risk. Journal of Racial and Ethnic Health Disparities. 11(3). 1509–1519. 5 indexed citations
6.
Chung, Dongjun, et al.. (2022). Association of Referral Source and Substance Use with Hepatitis C Virus Outcomes at a Southern Academic Medical Center. Southern Medical Journal. 115(6). 352–357. 1 indexed citations
7.
Novotny, Laura A., J.G. Evans, Lishan Su, Haitao Guo, & Eric G. Meissner. (2021). Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies. Viruses. 13(6). 1090–1090. 10 indexed citations
8.
Fonner, Virginia A., et al.. (2021). Patient-Provider Text Messaging and Video Calling Among Case-Managed Patients Living With HIV: Formative Acceptability and Feasibility Study. JMIR Formative Research. 5(5). e22513–e22513. 6 indexed citations
9.
Xu, Wenjie, et al.. (2020). Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection. BMC Infectious Diseases. 20(1). 929–929. 4 indexed citations
10.
Muiruri, Charles, Chris T. Longenecker, Eric G. Meissner, et al.. (2020). Prevention of cardiovascular disease for historically marginalized racial and ethnic groups living with HIV: A narrative review of the literature. Progress in Cardiovascular Diseases. 63(2). 142–148. 7 indexed citations
11.
Lazenby, Gweneth B., et al.. (2019). Increasing Prevalence of Chronic Hepatitis C Virus Infection in a Southern Academic Obstetrical Clinic. Southern Medical Journal. 112(6). 325–330. 8 indexed citations
12.
Shrivastava, Shikha, Eric G. Meissner, Emily K. Funk, et al.. (2016). Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitis. Hepatology International. 10(6). 937–946. 15 indexed citations
13.
Eckard, Allison Ross, Eric G. Meissner, Inderjit Singh, & Grace A. McComsey. (2016). Cardiovascular Disease, Statins, and HIV. The Journal of Infectious Diseases. 214(suppl 2). S83–S92. 21 indexed citations
14.
Townsend, Kerry, Eric G. Meissner, Sreetha Sidharthan, et al.. (2015). Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration. AIDS Research and Human Retroviruses. 32(5). 456–462. 28 indexed citations
15.
Barrett, Lisa Feldman, Anu Osinusi, Anita Kohli, et al.. (2013). 1 ALTERED HCV SPECIFIC T CELL IMMUNITY VERY EARLY IN INTERFERON FREE HCV DAA THERAPY. Journal of Hepatology. 58. S1–S1. 13 indexed citations
16.
Meissner, Eric G., Dimitra Bon, Ludmila Prokunina‐Olsson, et al.. (2013). IFNL4-ΔG Genotype Is Associated With Slower Viral Clearance in Hepatitis C, Genotype-1 Patients Treated With Sofosbuvir and Ribavirin. The Journal of Infectious Diseases. 209(11). 1700–1704. 76 indexed citations
17.
Haggarty, Beth, Katrina M. Nolan, Josephine Romano, et al.. (2007). V3 Loop Truncations in HIV-1 Envelope Impart Resistance to Coreceptor Inhibitors and Enhanced Sensitivity to Neutralizing Antibodies. PLoS Pathogens. 3(8). e117–e117. 65 indexed citations
18.
19.
Meissner, Eric G., Karen Duus, Feng Gao, Xiao-Fang Yu, & Lishan Su. (2004). Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope. Virology. 328(1). 74–88. 41 indexed citations
20.
Kleine, Peter, et al.. (1986). Effects of Clonidine and Nifedipine on Left Ventricular Hypertrophy and Muscle Mass in Hypertensive Patients. Journal of Cardiovascular Pharmacology. 10. S180–S186. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Kuntzen Breakdown of academic impact, for papers by Norma Rallón Breakdown of academic impact, for papers by H.‐H. Brackmann Breakdown of academic impact, for papers by Daniel S. Fierer Breakdown of academic impact, for papers by Rosemary Ffrench Breakdown of academic impact, for papers by Barbara McGovern Breakdown of academic impact, for papers by Deborah Casson Breakdown of academic impact, for papers by W. P. Schaasberg Breakdown of academic impact, for papers by Tilman Gerlach Breakdown of academic impact, for papers by Fayez M. Hamzeh
Rankless by CCL
2026